CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes EVP, Corporate Affairs & GC gave up 241 shares (to pay taxes)
- 4 Planned sale Chief Financial Officer sold 2,500 shares at $118.08 ($295,200)
- 4 Planned sale Chief Commercial Officer sold 3,000 shares at $118.08 ($354,240)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Open-market buy 10% owner bought 2,295,920 shares
- 4 Planned sale Chairman & CEO sold 10,000 shares at an average $111.66 ($1,116,564)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Commercial Officer sold 3,000 shares at $113.57 ($340,710)
- 4 Planned sale Chief Financial Officer sold 2,500 shares at $113.57 ($283,925)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chairman & CEO gave up 4,949 shares (to pay taxes)
- 4 Shares withheld for taxes Interim Corp Controller & CAO gave up 338 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Corporate Affairs & GC gave up 634 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,819 shares (to pay taxes)
Page 10 of 160 · 3,186 filings